Plasma-Seq follow-up CSPC4

We performed serial plasma-Seq analyses on a male who progressed from castration-sensitive to castration-resistant prostate cancer within 10 months following treatment with androgen-deprivation therapy.

本研究对一名在接受雄激素剥夺疗法治疗后，在10个月内从去势敏感型前列腺癌进展为去势抵抗型前列腺癌的男性进行了连续血浆测序分析。